Clinical trial
Phase II Study of Hydroxyurea for Unresectable Meningioma
NCT00003590 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Hydroxyurea for Unresectable Meningioma
- Lead sponsor
- SWOG Cancer Research Network
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 1998
- Completion date
- July 31, 2011
- Enrollment
- 29 (actual)
- Sites
- 133
Conditions
As the registry lists them; a condition with its own page is linked.
adult meningioma